Sage Journals: Discover world-class research

Abstract

Angelica sinensis Radix (ASR), one of the most commonly used traditional Chinese medicines, contains many chemical components such as polysaccharides, volatile oil, flavonoids, amino acids, and organic acids, among which polysaccharides play an indispensable role in the therapeutic effect of ASR. A. sinensis polysaccharide (ASP) has many biological activities, for instance, hematopoietic, anti-tumor, and liver protection, which are closely related to the treatment of human diseases such as chronic anemia, leukemia, and diabetes. In addition, there are excellent application prospects for drug delivery in nanoparticles. This paper reviews the chemical compositions, extraction methods, biological activity, action mechanism, potential clinical applications, nanoparticles, and research prospect of ASP from 2010 to 2020, so as to provide references for its further development.

Keywords

extraction biological activity potential clinical applications nanoparticles prospects

Angelica sinensis radix (ASR), the dried roots of Angelica sinensis (Oliv.) Diels (Apiaceae), has been widely used as a tonic to treat various diseases in China for thousands of years.^1,2 ASR has been reported to have a host of biological activities, such as activating blood circulation and replenishing blood, delaying senescence, and fighting cancer.^3,4 ASR contains more than 70 components, including polysaccharides, organic acids, volatile oils, and flavonoids. Among them, Angelica sinensis polysaccharides (ASP) are the primary components, which play an important role in the blood enrichment properties of ASR.⁵ In addition, ASP have antioxidant, blood circulation invigorating, anti-tumor, hepatoprotective, anti-aging, and anti-inflammatory effects, as well as excellent drug delivery and immunomodulatory properties, which offer considerable research and application potential.^6,7 Jin et al. mainly reviewed the extraction and purification technology, structural characterization, and biological activity of ASP before 2010.⁸ Therefore, this paper provides a comprehensive overview summarizing the chemical composition, extraction methods, biological activity, action mechanisms and applications of ASP from 2010 to 2020.

Search Strategy

For conducting a preliminary search, several databases were searched from 2010 to 2020, including Science Direct (Elsevier), PubMed Central, Web of Science, and Google Scholar to retrieve published studies regarding ASP. The following search keywords were used: (“Angelica sinensis polysaccharides”) and (“effects” OR “bioactivities” OR “structure” OR “extract” OR "“isolate”). First of all, the title and abstract of the obtained papers were screened. Then, the full text of the papers that passed the primary selection were screened again.

Chemical Composition and Characterization

The powdered roots were extracted with water. To the aqueous extract, ethanol was added and the precipitate obtained was dialyzed, freeze-thawed, and lyophilized to obtain crude polysaccharide. This was packed into a DEAE-Sephadex A-25 column (90 cm × 5 cm), which was eluted first with water, and then 0.3 M and 0.5 M NaCl in turn. The 0.5 M NaCl eluate was collected, dialyzed, and freeze-dried to obtain APS-3. This was further purified on a Sephacryl S-400 column (100 cm × 3.5 cm), eluting with 0.1 M NaCl, to obtain 3 sub-fractions, which were treated on Sephadex G100 (100 cm × 3.5 cm) columns. Three acidic polysaccharides, APS-3a, APS-3b and APS-3c, were obtained. Their sugar content was 63.7%, 67.9% and 61.0%, uronic acid content 25.1%, 30.3%, and 35.7%, and molecular weights 5.9 × 10⁵, 2.3 × 10⁵, and 1.4 × 10⁴ Da, respectively. APS-3a and APS-3b were composed of glucose, galactose, arabinose, rhamnose, and mannose with molar ratios of 3.2:1.7:2.5:1.3:1.0 and 2.3:5.4:6.8:1.0:1.2, respectively, while APS-3c was composed of glucose, galactose, arabinose, rhamnose, mannose, and xylose with a molar ratio of 6.3:4.7:6.7:6.5:1.6:1.0.³

Sliced roots were extracted with water, the pH of the extract was adjusted to 5-6, and then the crude polysaccharide was obtained by ethanol precipitation. The crude polysaccharide was then dissolved in water, freeze-thawed, filtered, and eluted with water on a Sephadex G-50 (80 cm × 3 cm) column. Mu et al. finally extracted an acidic heteropolysaccharide with a molecular weight of 8 × 10⁴ Da, which was composed of glucuronic acid, glucose, arabinose, and galactose with molar ratios of 1.00:1.70:1.85:5.02. Its backbone was composed of 1, 3-linked Galp, 1, 6-linked Galp, and 2-OMe-1, 6-linked Galp with 3 branches connected to O-3 of 2-OMe-1, 6-linked Galp, and the ends are GlcpA and Araf; all the Araf and most of the Glcp were distributed in branched chains. The chemical structure is shown in Figure 1(A).⁶

Figure 1

Chemical structure of ASP.

The sliced roots were extracted with water and then the alkaline and acidic proteins were removed with Ca(OH)₂ and 3 M H₂SO₄, followed by ethanol precipitation and dialysis, and finally, chromatography with Sephadex G-50. Thereafter, Wang et al. found a polysaccharide, the molecular weight of which was 7.29 × 10⁴ Da, composed of arabinose, glucose and galactose with a ratio of 1:2.5:7.5.⁹

The dried roots were extracted with water. After addition of ethanol to the extract, the precipitated crude polysaccharides were collected, then dialyzed, freeze-thawed, and lyophilized. A polysaccharide was extracted with a carbohydrate content of 97%, the monosaccharide components of which were arabinose, glucose, rhamnose, galactose, and galacturonic acid, with a ratio of 10.4:4.7:1.0: 5.2:8.0.¹⁰

Zhuang et al. determined the chemical structure of novel polysaccharides, as shown in Figure 1(B).¹¹ Water extraction of powdered roots was carried out by regulating the pH to remove acidic and basic proteins, then the polysaccharides precipitated with ethanol were collected and separated on a Sephadex G-50 column (35 cm × 3 cm) by eluting with water. Then Liu et al. isolated a new polysaccharide with a molecular weight of 7.8 × 10⁴ Da, and a total sugar content of 95%, composed of arabinose, glucose, and galactose, with a molar ratio of 1:5.68:3.91.^12,13 Crude polysaccharides were obtained from powdered roots by water extraction, ethanol precipitation, dialysis, freeze-thaw, and lyophilization. The crude polysaccharides were loaded into a DEAE Sephadex A-25 column (80 cm × 5 cm), and eluted with distilled water, and then 0.1 M, 0.3 M, and 0.5 M NaCl, respectively. Four polysaccharides, APS-0, APS-1, APS-3, and APS-5, were obtained. APS-1 and APS-3 were further separated by Superdex 200 (100 cm × 3 cm). Thereafter Zhang et al. isolated 2 hoursomogeneous polysaccharides, APS-1a and APS-3a, with molecular weights of 49 and 6.54 × 10⁴ Da, which were both composed of galactose, arabinose and glucose, with molar ratios of 57.34, 27.67, 14.98 and 84.54, 6.50, 8.96, respectively. APS-1a and APS-3a were mainly composed of 1,4-linked galactose, 1,3,6-linked galactose, T-galactose and T-arabinose, and the molar ratio of each bond in APS-1a and APS-3a was different.¹⁴

The sliced roots were extracted with water and then the alkaline and acidic proteins were removed by adjusting the pH to 4-5 with 3 M H₂SO₄, followed by ethanol precipitation and lyophilization. Cheng et al. found a homogeneous ASP with a molecular weight of 8.09 × 10⁴ Da and a sugar content of 88.0%, mainly composed of arabinose, glucose, and galactose with a ratio of 1:1:1.75.¹⁵ The roots were successively extracted with NaOH aqueous solution, the polysaccharides precipitated with ethanol, the protein removed with CHCl₃-n-BuOH, and then dialyzed with water to obtain crude polysaccharide. This was packed into different columns in turn. A DEAE-Sephadex A-25 column (80 cm × 4 cm) was eluted with distilled water, a Sephadex G-100 column (100 cm × 5 cm) was eluted with 0.1 M NaCl, and a Sephadex G-100 column was eluted with distilled water. Liu et al. finally extracted a homogeneous polysaccharide APS-1II with a molecular weight of 4.21 × 10⁴ Da, and determined that it was composed of arabinose, glucose, and fucose with a molar ratio of 2.42:1.05:1.00. The backbone of APS-1II consisted of 1,3-α-L-Araf and 1,6-α-D-Glcp and the branched chain contained 1,5-α-L-Araf, 1,4-β-D-Glcp, T-β-D-Glcp, 1,3-α-L-Fucp, and T-α-L-Fucp.¹⁶

The roots were first extracted with water, the polysaccharides precipitated with ethanol, and the protein and pigments removed with papain, CHCl₃-n-BuOH, and H₂O₂. After dialysis and freeze-drying, the material was separated on a Sephadex G-100 column (65 cm × 3 cm) by eluting with water.

Polysaccharides were extracted by Ji et al. from unprocessed Chinese Angelica (UCA), Angelica parched with alcohol (ACA), Chinese Angelica parched with sesame oil (OCA), Chinese Angelica parched with soil (SCA), and charred Chinese Angelica (CCA). The carbohydrate contents of UCA polysaccharide (UCAP), ACAP, OCAP, SCAP, and CCAP were 91.5%, 93.1%, 88.6%, 89.9%, and 88%. Their monosaccharide compositions were all rhamnose, arabinose, mannose, glucose, and galactose, but in ratios of 3.9:35.8:3.1:29.9:28.1, 4.5:41.2:3.6:32.3:32.1, 4.1:40.1:3.3:30.6:31.3, 4.4:39.5:3.2:31.9:29.2, and 4.7:55.4:3.7: 31.6:30.2, respectively.¹⁷

Crude polysaccharides were obtained by water extraction and ethanol precipitation. The crude polysaccharides were extracted with water again, and precipitated by ethanol 1 step precipitation and fractional precipitation. Wang et al. separated Chinese Angelica sinensis polysaccharides 30 (CAPS30), CAPS50, CAPS70, CAPS80, and total CAPS (CAPSt), and determined their carbohydrate contents as 90.31%, 85.50%, 86.95%, 88.62%, and 90.74%, and their molecular weights as 2.621 × 10⁴, 2.07 × 10⁴, 2.082 × 10⁴, 2.719 × 10⁴, and 2.083 × 10⁴ Da, respectively. CAPS30 and CAPS80 contained arabinose, mannose, glucose, and galactose with molar ratios of 1.21:33.06:63.99:1.29 and 2.31:3.68:91.29:2.14, respectively. Mannose and glucose were the main components of CAPS50 and CAPS70 with a molar ratio of 1.05:86.22 and 1.20:1.01; the molar ratios of xylose and mannose were 1.92:1.00 in CAPSt.¹⁸

The sliced roots were soaked in NaOH solution and the polysaccharides precipitated with ethanol. After protein removal with CHCl₃-n-BuOH, the material was freeze-dried to obtain the crude polysaccharides. The crude polysaccharides were packed into a DEAE Sephadex A-25 column and eluted with distilled water, then 0.5 M, 1 M, and 2 M NaCl solution in turn. Then the material was fractionated on a Sephadex G-100 column (100 cm × 5 cm) by eluting with 0.1 M NaCl, followed by a Sephadex G-100 column eluting with distilled water. Liu et al. found a new heterogeneous ASP, called APS-2I, whose molecular weight was 7.2 × 10⁵ Da, the main components of which were mannose, rhamnose, galacturonic acid, glucose, galactose, and arabinose, with a ratio of 4:5:1:10:23:39. The backbone of APS-2I was composed of 1,4-GalpA, 1,3-Rhap, 1,2,6-Manp, 1,6-Galp, and 1,2-Manp, and the branched chains contained TAraf, 1,4-Galp, 1,3-Araf, 1,5-Araf, 1,3,5-Araf,and 1,6-Galp.¹⁹

The sliced roots were extracted with water, and the crude polysaccharides precipitated with ethanol were collected dialyzed and lyophilized. The crude polysaccharides were packed into a DEAE-Sepharose CL6B column (D 30 cm × 2.6 cm) and eluted successively with distilled water and a NaCl gradient (0, 1 M). Sun et al. finally isolated neutral polysaccharide ASP1, as well as acidic polysaccharides ASP2 and ASP3 from ASR. The molecular weight of ASP3 was determined to be 3.4 × 10⁴ Da. ASP1 was found to be mainly composed of (65.00) glucose, (3.66) galactose, and (9.15) arabinose, while the contents of galacturonic acid, rhamnose, arabinose, and galactose in ASP2 and ASP3 were 35.38, 1.11, 16.31, 15.75 and 58.27, 1.87, 10.50, 24.93, respectively.²⁰

The powdered roots were extracted with water, the protein removed by Sevag, and the polysaccharides precipitated with ethanol and lyophilized. The product was loaded into a DEAE-52 cellulose anion exchange column (30 cm × 2.6 cm) and eluted with phosphate buffer and a gradient of NaCl (0.05, 1 M), respectively. Pan et al. discovered a neutral heteropolysaccharide with a molecular weight 8.2 × 10⁴ Da, which was composed of arabinose, galactose, and glucose in ratios of 6:1:1.²¹ The monosaccharide composition is shown in Table 1.

Table 1

Composition and Characterizations of Polysaccharides.

No.	Compound name	Monosaccharide compositions (molar ratio)									Molecular weight(Da)	Reference
No.	Compound name	Glucose	Galactose	Arabinose	Rhamnose	Mannose	Xylose	Glucuronic acid	Fucose	Galacturonic acid	Molecular weight(Da)	Reference
1	APS-3a	3.20	1.70	2.50	1.30	1.00					5.9 × 10⁵	³
2	APS-3b	2.30	5.40	6.80	1.00	1.20					2.3 × 10⁵	³
3	APS-3c	6.30	4.70	6.70	6.50	1.60	1.00				1.4 × 10⁴	³
4		1.70	5.02	1.85				1.00			8 × 10⁴	⁶
5		2.50	7.50	1.00							7.29 × 10⁴	⁹
6		4.70	5.20	10.40	1.00			8.00				¹⁰
7		5.68	3.91	1.00							7.8 × 10⁴	¹³
8	APS-1a	14.98	57.34	27.67							4.9 × 10⁴	¹⁴
9	APS-3a	8.96	84.54	6.50							6.54 × 10⁴	¹⁴
10		1.00	1.75	1.00							8.09 × 10⁴	¹⁵
11	APS-1II	1.05		2.42					1.00		4.21 × 10⁴	¹⁶
12	UCAP	29.90	28.10	35.80	3.90	3.10						¹⁷
13	ACAP	32.30	32.10	41.20	4.50	3.60						¹⁷
14	OCAP	30.60	31.30	40.10	4.10	3.30						¹⁷
15	SCAP	31.90	29.20	39.50	4.40	3.20						¹⁷
16	CCAP	31.60	30.20	55.40	4.70	3.70						¹⁷
17	CAPS30	63.99	1.29	1.21		33.06					2.621 × 10⁴	¹⁸
18	CAPS50	86.22				1.05					2.07 × 10⁴	¹⁸
19	CAPS70	1.01				1.20					2.082 × 10⁴	¹⁸
20	CAPS80	91.29	2.14	2.31		3.68					2.719 × 10⁴	¹⁸
21	CAPSt					1.00	1.92				2.083 × 10⁴	¹⁸
22	APS-2I	10.00	23.00	39.00	5.00	4.00				1.00	7.2 × 10⁵	¹⁹
23	ASP1	65.00	3.66	9.15								²⁰
24	ASP2		15.75	16.31	1.11			35.38				²⁰
25	ASP3		24.93	10.50	1.87			58.27			3.4 × 10⁴	²⁰
26		1.00	1.00	6.00							8.2 × 10⁴	²¹

Extraction Methods and Optimization

Extraction is a key step for obtaining polysaccharides from ASR and there are more than one extraction methods, including hot water, acid-alkali, and enzymatic extraction methods. There are many factors affecting the extraction efficiency of polysaccharides, the most important of which are the ratio of liquid to solid, extraction time, extraction temperature, and ultrasonic power for ultrasonic-assisted extraction.^22,23

Hot water is used for extraction, and the relationship between response function and process variables is identified by Box-Behnken design (BBD) and orthogonal array experimental design (OAD) to maximize the extraction yield. The results show that the best extraction conditions are as follows: extraction time 130 minutes (min), ratio of liquid to solid 5, and extraction number 5, then the extraction rate of ASP can be as high as 5.83%, but is actually 5.6%²⁴; extraction time 180 minutes, ratio of water to solid 6, extraction number 4 and extraction temperature 100 °C, then the extraction rate of ASP can reach up to 5.6%.²⁵

When ultrasonic-assisted extraction is used, the extraction method is analyzed and optimized by single factor experiment, OAD and BBD. The optimal extraction conditions are as follows: ratio of liquid to solid 43.31, ultrasound power 396.83 w, extraction time 28.06 minutes, and ASP yield 21.89%²³; ratio of liquid to solid 7, ultrasound power 180 w, extraction time 45 minutes, extraction temperature 90 °C, and ASP yield 6.96%.²⁶ These methods are presented in Table 2.

Table 2

ASP Extraction Methods.

Extraction methods	Ultrasound-assisted extraction	Hot water extraction	Hot water extraction	Ultrasound-assisted extraction
Ultrasound power (w)	396.83	\	\	180
Ratio of liquid to solid	43.31	5	6	7
Extraction time (min)	28.06	130	180	45
Extraction temperature (°C)	\	100	100	90
Extraction number	3	5	4	\
Extraction solvent	water	Water	Water	Water
ASP yield (%)Reference	21.89 ²³	5.60 ²⁴	5.60 ²⁵	6.96 ²⁶

From the above results, it can be found that the actual extraction rates of the 2 water extraction methods are basically the same, and the reason may be that the extraction of ASP by this method has reached the limit. Therefore, with increasing ASP study, the extraction method also needs to be further improved.

Through comparison of the ASP yields mentioned above, we may come to a reliable conclusion that compared with water extraction, ultrasound-assisted extraction has a shorter extraction time and higher extraction rate. Ultrasonic-assisted extraction is cheap, easy to implement and more efficient. It can also exert mechanical effects to make more solvent penetrate into the tissue and increase the contact surface area between solids and liquids. Accordingly, the solute diffuses rapidly from the solid phase to the solvent.²⁶

Biological Activities

Hematopoietic Activity

Anemia caused by iron metabolism disorder is a prevalent clinical disease, which can be divided into 2 major categories: one is iron metabolism abnormality, the other is iron deficiency anemia (IDA), but hepcidin can regulate plasma iron levels. As a result, hepcidin has gradually become a potential target for the therapies of iron deficiency diseases and is affected by iron status, erythropoiesis, hypoxia, and inflammation.²⁷

More recently, erythropoietin (EPO) has been shown to inhibit effectively the expression of hepcidin by promoting erythropoiesis in vivo, and is used to treat anemia caused by hepcidin, while ASP can promote the secretion of EPO and down-regulate the level of hepcidin in IDA rats.¹³ Related studies have shown that ASP can promote the recovery of hemoglobin in mice with acute blood loss, and hematopoietic activity is achieved through the secretion stimulation of hematopoietic growth factors, such as granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin-3 (IL-3).^2,28 ASP can enhance EPO secretion, decrease the level of hepcidin and alleviate hematopoietic injury in mice after whole body irradiation.^14,29 It can also block Janus-kinase/signal transducers and activators of the transcription proteins (JAK-STAT), extracellular signal-regulated kinase (ERK),^27,29,30 IL-6/STAT3, and bone morphogenetic protein-mothers against the decapentaplegic protein (BMP-SMAD) pathways, thus inhibiting the expression of hepcidin, improving the utilization of iron, eliminating the suppression of inflammatory cytokines on erythropoiesis, and blocking the activation of inflammatory hepcidin and nuclear factor kappa-B (NF-κB) to treat rats with anemia of chronic disease (ACD).^31,32 Furthermore, ASP promotes the production of EPO in kidney and liver by stabilizing hypoxia inducible transcription factor-2α (HIF-2α) protein and weakening inflammatory inhibition, and it repairs the EPO receptor (EPOR) signaling system and increases iron utilization by inhibiting hepcidin and inflammation, thus treating anemia in rats with chronic nephropathy.³³

Liu et al. suggested that the hematopoietic and thrombopoietic effects of ASP may result from the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathways.³⁴ In addition, ASP can increase the number of red blood cells and the content of hemoglobin^35
-37 by up-regulating theexpression of cyclin D1 and Bcl-2 protein.³⁸ At the same time, ASP can stimulate EPO secretion and regulate the pathway of erythropoiesis, and so the level ofhepcidin mRNA decreased with the increase in erythropoiesis rate.³⁰ Additionally, ASP can restore the function of hematopoietic stem cells viainhibiting aberrant T-cell immunity and inducing anti-mitochondrial apoptosisin patients with aplastic anemia.³⁹ The mechanism of hematopoietic activity is shown in Figure 2 and relevant pathways are summarized in Table 3.

Figure 2

Hematopoietic and antioxidant mechanism.

Table 3

Related Signal Pathways of ASP.

Biological activity	Compound name	Molecular weight (Da)	Molar ratio of monosaccharides									Pathways	Action mechanism	Reference
Biological activity	Compound name	Molecular weight (Da)	Arabinose	Glucose	Rhamnose	Galactose	Mannose	Xylose	Fucose	Galacturonic acid	Glucuronic acid	Pathways	Action mechanism	Reference
Hematopoietic activity	ASP	7.8 × 10⁴	1	5.68		3.91						Inhibit SMAD4, C/EBPα	Down-regulate hepcidin expression	¹³
	ASP	7.29 × 10⁴	1	2.5		7.5						Inhibit JAK, SMAD, ERK	Down-regulate hepcidin expression	²⁷
	ASP I + II (7.5:1)	7.6 × 10⁴										Inhibit JAK2, SMAD1/5/8	Down-regulate hepcidin expression	³⁰
	ASP											Inhibit IL-6/STAT3, BMP/SMAD	Down-regulate hepcidin expression	³¹
	ASP	8 × 10⁴	1.85	1.7		5.02					1	Inhibit GATA2, NF-κB	Improve EPO	³³
Antioxidant activity	ASP	7.29 × 10⁴	1	2.5		7.5						Upregulate PPARγ; activate adiponectin-SIRT1-AMPK	Alleviate lipid disorders	⁴⁰
	ASP											Activate ATF6	Ameliorate ER stress and oxidative stress	⁴¹
	ASP											Inhibit MAPK	Antioxidative effects	⁴²
	ASP	8.5 × 10⁴	8.7	15	21.3	13.6		3.7	1			Up-regulate PPARγ	Anti-oxidation of OA	¹¹
	ASP											Up-regulate miR-126	Attenuate cellular oxidative damage	⁴³
Antitumor activity	ASP											Activate CREB, Caspase-3, ROCK1/Mlc	Inhibit the tumor growth of breast caner	¹²
	ASP											Inhibit JAK/STAT, BMP-SMAD	Regulate hepcidin expression	³²
	ASP	7.29 × 10⁴										Down-regulate PI3K/Akt, JAK/STAT	Repress tumorigenesis	⁴⁴
	ASP											Inhibit PI3K/Akt, ERK1/2	Inhibit tumor cell growth	⁴⁵
	ASP											Inhibit TGF-β	Attenuate the tumorigenicity of glioma cells	⁴⁶
Hepato-protective activity	ASP	8 × 10⁴	1.85	1.7		5.02					1	Up-regulate Bcl-2/Bax; block caspase-9/3/8	Inhibit apoptosis in pancreatic islet β-cells	²²
	ASP	7.29 × 10⁴	1	2.5		7.5						Inhibit IL-6/STAT3, NF-κB, Caspase-8, JNK	Protect the liver from the viral and autoimmune hepatitis	⁴⁷
	ASP											Inhibit MAPK	Hepatoprotective effects	⁴²
Anti-aging activity	ASP											Inhibit p16Ink4a-RB, p19Arf-p21Cip1/Waf, Wnt/β-catenin	Prevent senescence of HSCs	⁴⁸
	ASP		10.4	4.7	1	5.2				8		Activate the Akt/ hTERT	Induce telomerase activity	¹⁰
	ASP	7.29 × 10⁴										Down-regulate p53/p21	Delay aging speed	⁴⁹
Anti-inflammatory activity	APS-3c	1.4 × 10⁴	6.7	6.3	6.5	4.7	1.6	1				Activate IGF1/IGF1R	Anti-OA activity	⁵⁰
	ASP											Down-regulate Gab2/PI3K/Akt, Fyn/Syk	Inhibit the activation of mast cells	⁵¹
	ASP											Down-regulate COX-1	Alleviate LPS-induced inflammation	⁵²
	ASP											Inactivate NF-κB	Alleviate LPS-induced inflammation	⁵³
	ASP											Inhibit NF-κB, JAK2/STAT3	Weaken LPS-evoked inflammatory injury	⁵⁴
	ASP											Activate Nrf2/HO-1; inactivate NF-κB	Alleviate LPS-induced inflammatory injury	⁵⁵
Myocardial protective activity	ASP											Activate ATF6, AMPK-PGC1α	Protect the heart against ischemic injury	⁵⁶

Antioxidant Activity

Oxidative stress, a key participant that leads to apoptosis, is closely related to ischemia-reperfusion injury, high-fat diet, and exhaustive exercise.^26,40,57

ASP could enhance the antioxidant components in rat models with myocardial ischemia reperfusion (MIR), such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and glutathione (GSH).^41,57
-59 The concentration of malondialdehyde (MDA), reactive oxygen species (ROS), and nitric oxide (NO) in brain tissue of cerebral ischemia reperfusion (CIR) rats treated with ASP also significantly decreased, while the activities of antioxidant enzymes increased,^25,60 suggesting that ASP could significantly reduce oxidative stress injury both in brain and heart caused by ischemia-reperfusion. In other studies, ASP could remarkably lower concentrations of ROS and MDA, as well as increase the levels of GSH and GSH-Px in livers of rat models with high-fat diet.⁴⁰ In addition, ASP also could strengthen the activities of SOD, CAT, GSH, GSH-Px, and glutathione reductase (GR) in the skeletal muscles of exhaustive exercise rats.²⁶

Lai et al. found that oxidized low density lipoprotein (ox-LDL) increased intracellular oxidative stress, which could be weakened by ASP. Moreover, ASP down-regulated the expression of gp91-phox, thus inhibiting the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. This inhibition decreased intracellular superoxide ion levels and oxidative stress in endothelial progenitor cells (EPCs).¹⁰ In addition, the results showed that ASP had a scavenging effect on 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl radical, and superoxide anion radical, thereby showing antioxidation.^42,61 ASP suppressed H₂O₂-mediated oxidative stress injury of human chondrocytes by up-regulating PPARγ and down-regulating inducible nitric oxide synthase (iNOS).¹¹ Furthermore, it also could significantly increase the level of total antioxidant capacity (T-AOC),⁴⁹ upregulate MicroRNA (miR)−126 and decrease lactate dehydrogenase and ROS products in H9c2 and HaCaT cells treated with H₂O₂, thus decreasing oxidative damage.^41,43 The mechanism of antioxidant activity is shown in Figure 2 and relevant pathways are summarized in Table 3.

Antitumor Activity

Cancer is one of the most pervasive and deadly human diseases in the world, killing more than 10 million people each year. Current cancer treatments mainly include surgery, radiotherapy and chemotherapy, which often kill healthy cells and cause poisoning. Hence, researchers are looking for ways to eliminate only cancer cells.⁶²

Zhuang et al. found that ASP could effectively induce apoptosis of human breast cancer cells T47D and Hs578T and inhibit the growth of breast cancer xenografts. Its effects are related to the activation of the cyclic AMP response element binding protein (CREB), caspase-3, rho-associated coiled-coil-containing protein kinase1 (ROCK1) activation, and myosin light chain phosphorylation.¹² ASP was also capable of inhibiting the proliferation of tumor cell lines HepG2, MCF-7, and A549 in vitro.⁶ Additionally, it also could exert its anti-tumor activity by regulating iron metabolism, which might make hepcidin, IL-6, ferritin, transferrin (Tf), transferrin receptor 1 (TfR1), and TfR2 become targets of tumor therapy.^15,32 ASP could inhibit the proliferation, migration, invasion, and induce apoptosis of SH-SY5Y cells. It might inactivate PI3K/Akt and JAK/STAT signaling pathways via down-regulating miR-675 in SH-SY5Y cells, thereby inhibiting the tumorigenicity of SH-SY5Y cells.⁴⁴ Furthermore, ASP could block the growth of SH-SY5Y cells, the process of epithelial-mesenchymal transformation, as well as the PI3K/Akt and ERK1/2 signal pathways, which were achieved by up-regulating miR-205 with zinc finger E-box binding homeobox 1 as the target gene.⁴⁵ At the same time, ASP showed an inhibitory effect on the proliferation and cell cycle progression of U251 glioma cells, and induced apoptosis by stimulating the expression of E-cadherin through the transformation of the growth factor (TGF)-β signal pathway.⁴⁶

ASP could dramatically prolong the survival time of L1210 tumor-bearing mice. Its anti-leukemia effect was connected with the activation of leukocytes and lymphocytes in peripheral blood, inhibiting the secretion of cytokines tumor necrosis factor (TNF-α), interferon-γ (IFN-γ), and IL-2, thereby facilitating the proliferation of splenocytes, strengthening the phagocytic activity of peritoneal macrophages, and killing activity of natural killer (NK) cells.¹⁶ ASP could dramatically suppress the proliferation of human acute myelogenous leukemia (AML) CD34⁺CD38^-cells in vitro. In addition, ASP had an obvious cytotoxic effect on AML K562 cells, especially CD34⁺CD38^-cells enriched by leukemia stem cells (LSC). It could significantly inhibit the colony formation of AML CD34⁺ CD38^-cells. The potential mechanism of ASP-induced cell senescence was closely correlated to the upregulation of p53, p16, p21, and Rb genes, the changes of related cell cycle regulatory proteins P16, P21, cyclin E and Cell Cycle Dependent Kinase 4, telomere wear, and inhibition of telomerase activity.⁶³ ASP could suppress the proliferation of chronic myeloid leukemia K562 cells, and its mechanism had association with the induction of erythroid differentiation. In the process of erythroid differentiation of K562 cells induced by ASP, the results suggested that the JAK2/STAT5 signal played an indispensable role in erythroid differentiation of human myeloid leukemia cell line K562 induced by ASP. ASP induced erythroid differentiation of K562 cells through the JAK2/STAT5 signal pathway, and its potential mechanism might be attributed to the increased EPO response.⁶⁴ The mechanism of antitumor activity is shown in Figure 3 and relevant pathways are summarized in Table 3.

Figure 3

Antitumor and hepatoprotective mechanism.

Hepatoprotective Activity

In China, liver diseases, mainly viral hepatitis (primarily hepatitis B virus), non-alcoholic fatty liver disease, and alcoholic liver disease affect about 300 million people, which have a significant impact on the global burden. Therefore, it is imperative to explore liver protective drugs.⁶⁵

ASP could remarkably reduce the concentration of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyl transpeptidase (γ-GT) in plasma,⁶⁶ and also significantly alleviate liver injury caused by hepatocyte apoptosis⁶⁷ and diabetes, whose mechanism might be related to the regulation of lipids, including a decrease in serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) concentrations.²² ASP exerted its hepatoprotective effect by inhibiting the secretion of pro-inflammatory cytokines and apoptosis in liver injury induced by ConA, which includes serum TNF-α, IFN-γ, IL-2, and IL-6 levels, and the potential mechanism may block the signal transduction pathways mediated by NF-κB, IL-6/STAT3, caspase-8, and c-JunN-terminal kinase (JNK), and up-regulate the level of Bcl-2.^4,47 ASP remarkably decreased plasma MDA and alkaline phosphatase (ALP) activities, while the antioxidant defense capacity of major enzymes was significantly enhanced, such as SOD, GSH-Px, and CAT in the livers of rats treated with CCl₄ ²⁴. It also could significantly increase the level of serum total protein (TP) and inhibit the expression of p-ERK, p-JNK, and p-p38 in the mitogen-activated protein kinase (MAPK) signal pathway to resist liver dysfunction induced by CCl₄ in mice.⁴² The mechanism of hepatoprotective activity is shown in Figure 3 and relevant pathways are summarized in Table 3.

Anti-aging Activity

Cell senescence was first proposed by Hayflick and Moorhead in the 1960s as the irreversible stagnation of cells after long-term culture. Many factors, including various forms of stress, can accelerate cell senescence, such as oxidative stress, so how to delay and treat cell senescence has become a major concern in life and social sciences.⁶⁸

Mu et al. suggested that ASP could prevent the senescence of hematopoietic stem/progenitor cells (HSC/HPCs) induced by D-galactose (D-Gal) in mice via reducing the level of serum advanced glycation end products (AGEs) and the number of senescence associated β-galactosidase (SA-β-Gal) positive cells, as well as via promoting the formation of mixed colony forming unit (CFU-Mix). ASP prevented oxidative stress by increasing T-AOC and reducing the levels of ROS, 8-hydroxydeoxyguanosine and 4-hydroxynonenal. It decreased the expression of phosphorylated H2A.X (γ-H2A.X), which was the marker of DNA double-strand breaks, and lowered the subsequent ectopic expression of effectors in p16^INK4a-retinoblastoma (RB) and p19^Arf-p21^Cip1/Waf senescence pathways. Additionally, ASP could reduce the expression of β-catenin, Ser9-phosphorylated GSK-3β (phospho-GSK-3β), and T cell factor (TCF)−4, and inhibit cyto-nuclear translocation of β-catenin, thus blocking the over-activation of Wnt/β-catenin signal in aged HSC/HPCs.⁴⁸ Furthermore, ASP suppressed the senescence of EPCs mediated by ox-LDL, which is related to the decrease of SA-β-Gal positive cells, the recovery of telomerase activity and Akt/ human telomerase reverse transcriptase (hTERT) pathway.¹⁰ Aging is associated with oxidative damage and chronic inflammation. However, in D-gal-induced neural stem cells (NSCs), ASP could increase the activity of SOD and decrease the levels of MDA, IL-1b, IL-6, and TNF-α to play a protective role. It also could regulate the expression of these genes through decreasing the levels of p53 and p21 proteins, thereby delaying the aging of hippocampus and NSCs.⁴⁹ The mechanism of anti-aging activity is shown in Figure 4 and relevant pathways are summarized in Table 3.

Figure 4

Anti-aging and anti-inflammatory mechanism.

Anti-inflammatory Activity

ASP could enhance the expression of insulin like growth factor 1 (IGF1)/ IGF1 receptor (IGF1R) gene by promoting the expression of the UDP-sugar synthases (USSs) gene, thus accelerating glycosaminoglycan (GAG) synthesis and cartilage repair to exert its anti-osteoarthritis (OA) activity.⁵⁰ At the same time, ASP could facilitate and up-regulate the expression of aggrecan and GTs genes, thereby promoting proteoglycans (PGs) biosynthesis to treat rat OA.⁶⁹

In addition, ASP could remarkably inhibit the activation of RBL-2H3 cells, and it had a significant inhibitory effect on the release of pro-inflammatory cytokines, allergic mediators, and Ca²⁺ entry from RBL-2H3 cells stimulated by anti-dinitrophenol (DNP) immunoglobulin E (IgE). Treatment of ASP could suppress the expression of cytokines IL-1, IL-6, TNF-α, and NF-κB p65 inflammatory pathways. Furthermore, ASP could down-regulate the phosphorylation of Fyn in anti-DNP IgE-stimulated RBL-2H3 cells. The downstream phosphorylated signal molecules Gab2/PI3K/Akt and Fyn/Syk pathways, including p-Akt and p-P38, were also down-regulated in anti-DNP IgE-stimulated RBL-2H3 cells.⁵¹

ASP could attenuate lipopolysaccharide (LPS)-induced inflammatory damage in PC12 cells by decreasing IL-1β and IL-8 levels and cyclooxygenase-1 (COX-1). It might protect PC-12 cells from LPS-induced inflammatory injury by suppressing miR223, and inactivating the NF-κB pathway.^52,53 ASP could up-regulate the expression of miR-10a in HT22 cells and then inhibit NF-κB and JAK2/STAT3 pathways to alleviate LPS-treated inflammation. It also could attenuate inflammatory injury through up-regulating sirtuin 1(SIRT1) expression and activating the nuclear factor-erythroid 2-related factor (NrF2)/heme oxygenase-1 (HO-1) pathway in HACaT cells induced by LPS.^54,55 The mechanism of anti-inflammatory activity is shown in Figure 4 and relevant pathways are summarized in Table 3.

Myocardial Protective Activity

Myocardial infarction is one of the diseases with high morbidity and mortality worldwide, which is featured with cell death caused by long-term ischemia after coronary artery occlusion. In addition, reperfusion usually cannot be treated in time, and it can also cause myocardial injury, that is, ischemia reperfusion injury. Therefore, it is of great clinical significance to find a drug to protect the heart.⁵⁶

ASP stimulated the activating transcription factor 6 (ATF6) branch of unfolded protein response (UPR) and attenuated harmful endoplasmic reticulum (ER) stress in the ischemic heart animal model in vivo and oxygen-glucose deprivation (OGD)-induced H9c2 cells in vitro. The results showed that ASP could target the ATF6 branch of UPR through adenosine monophosphate-activated protein kinase (AMPK)-peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α) pathway, thus improving the heart injury caused by ischemia. Furthermore, ASP might alleviate hypoxia-induced H9c2 cell injury via down-regulating the expression of miR-22. ASP also could significantly enhance the pro-survival molecules in the ER stress response system, including glucose-regulated protein 78 (GRP78), GRP94, and protein disulfide isomerase associated 6 (PDIA6), and reduce the expression of pro-apoptotic factors. In addition, ASP could alleviate myocardial ischemic injury through its antioxidant and anti-inflammatory activities.^56,70 The mechanism of myocardial protective activity is shown in Figure 5 and relevant pathways are summarized in Table 3.

Figure 5

Myocardial protective and anti-fatigue mechanism.

Anti-fatigue Activity

Related articles suggest that ASP has an anti-fatigue effect, which could prolong the exhaustive swimming time of mice, decrease the production of blood lactic acid or promote the clearance of blood lactic acid, reduce the content of serum urea nitrogen, and increase the activities of blood glucose, hemoglobin and content of glycogen in liver and muscle.^61,71 Additionally, ASP could increase the glycogen reserve of liver and muscle and maintain the dynamic balance of the blood glucose level, which could guarantee the energy supply of the central nervous system, muscles, and erythrocytes and postpone the appearance of fatigue. Furthermore, ASP played a crucial role in fat metabolism, including the regulation of free fatty acid formation and the utilization of fat oxidation. At the same time, the antioxidant activity of ASP was helpful to protect the body from oxidative stress, thus to exert an anti-fatigue effect.⁵⁹ The mechanism of anti-fatigue activity is shown in Figure 5.

Other Activity

Sun et al. pretreated mice with ASP and then treated them with radiation. The results showed that the radiation-induced damage of mice in the ASP treatment group was significantly lower than that of the radiation control group, which proved that ASP had an anti-radiation effect, and the mechanism might be related to the protection of leukocytes and lymphocytes in mice.²⁰ Through in vitro assay, Xiao et al. found that ASP could improve the oxidative damage of bone marrow stromal cells and enhance their hematopoietic function to protect hematopoietic cells from stress-induced premature senescence, thus providing an effective treatment for chemotherapy-induced myelosuppression.⁷² Furthermore, ASP could significantly inhibit the formation of calcium oxalate crystals in cells. In vivo, the renal pathological changes and calcium oxalate deposition in ASP treated rats were significantly alleviated, and the levels of urinary oxidative stress, oxalic acid, creatinine, and urea in rats treated with ASP were significantly lower than those of ethylene glycol-induced renal stone rats. ASP may play this role by regulating the expression of P-JNK and kidney injury molecule-1 in the kidney of rats, which reflects the potential anti-urolithiasis effect of ASP.⁷³ By feeding white shrimp with ASP, Pan et al. found that ASP could improve the activities of phenoloxidase, SOD, and GSH-Px, increase the total number of blood cells and the number of clear cells, semigranular cells and granulosa cells, and enhance disease resistance to Vibrio alginolyticus. The potential immunostimulatory activity of ASP was demonstrated.²¹

Potential Clinical Applications

Anemia

IDA is a late symptom of iron deficiency and is the most prevalent category of anemia caused by inadequate iron storage, while hepcidin, as the main negative regulator of iron homeostasis, is mainly produced by the liver. Recently, hepcidin therapy for anemia has gradually become a research hotspot. Some studies showed that the stimulation of erythropoietin and the inhibition of SMAD4 expression participated in the inhibition of hepcidin expression induced by ASP, which blocked the phosphorylation of CCAAT/enhancer-binding protein α (C/EBPα) and STAT3/5, and then suppressed the expression of hepcidin in IDA rats.¹³ Further research showed that ASP could significantly reduce the expression of hepcidin through inhibiting SMAD, JAK, and ERK pathway, which might have a potential clinical value in the alleviation of diseases caused by overexpression of hepcidin.^27,30

ACD is the second most widespread anemia, which is an acquired disease that occurs concurrently with chronic or acute immune activation, such as infection, autoimmune disease, and cancer. Wang et al. found that ASP could suppress the inflammatory hepcidin response of HepG2 cells and ACD rats by inhibiting IL-6/STAT3 and BMP/SMAD signaling pathways. After ASP treatment, the expression of iron transport protein, serum iron level, and serum EPO in ACD rats increased. Moreover, iron from the liver and spleen was activated, and symptoms of anemia were significantly alleviated. What is more, ASP could suppress the activation of NF-κB p65 through the IκB kinase-IκBα pathway, thus decreasing the secretion of TNF-α, as well as alleviating the inhibition of erythropoiesis accordingly.³¹

Study on anemia in chronic nephropathy has shown that ASP could promote hypoxia-induced EPO production in Hep3B cells and its mechanism might be related to the equilibrium of HIF-2α protein. Wang et al. proposed that ASP could increase the stockpile of HIF-2α protein, decrease the expression of NF-κB, GATA binding protein 2 (GATA2) and pro-inflammatory cytokines, and stimulate the production of EPO in kidney and liver, thus leading to the increase of serum EPO. Meanwhile, ASP could relieve the inhibitory effect of pro-inflammatory factor TNF-α on EPO by suppressing the activation of GATA2 and NF-κB. In addition, ASP could repair the production of EPO and the expression of EPOR mRNA, induce the expression of target genes B-cell lymphoma-extra-large, Fam132b and Tfrc, and increase the ratio of Bcl-2/Bax in bone marrow mononuclear cells of chronic nephropathy rats, which might be involved in erythroid progenitor cell apoptosis, as well as iron ingestion and utilization in hemoglobin synthesis.³³

Osteoarthritis

Oxidative stress is involved in the apoptosis of chondrocytes, and ROS damages the cell membrane, protein, and DNA, resulting in pathological changes in the morphology and function of chondrocytes, which in turn leads to the apoptosis of chondrocytes. In addition, inflammatory cytokines are crucial to the occurrence and development of OA, while ASP could significantly reduce the levels of IL-1β and TNF-α, and apoptosis of chondrocytes. Furthermore, ASP might inhibit oxidative stress mediated by H₂O₂ through NF-κB and MAPKs signaling pathways in OA chondrocytes, increase the expression of anabolism genes Collagen type II alpha 1, aggrecan and SOX9, and suppress the expression of matrix metalloproteinase (MMPs) genes MMP-1, MMP-3, and MMP-9, thereby reducing the response of chondrocytes to H₂O₂, protecting chondrocytes, and promoting the recovery of injured chondrocytes.¹ ASP could inhibit the production of MDA, so as to reduce lipid peroxidation, up-regulate the expression of PPARγ, and down-regulate iNOS, then, consequently, the NO synthesis is decreased and H₂O₂-mediated oxidative stress damage of chondrocytes is alleviated.¹¹

The loss of GAG can result in continuous degeneration of joint cartilage. ASP could significantly promote GAG synthesis and cartilage repair, and its mechanism is related to the stimulation of USSs gene expression. It could also stimulate the expression of IGF1/IGF1R genes both in vivo and in vitro. Moreover, IGF1 can facilitate the synthesis and secretion of GAG in chondrocytes, thus improving the level of USSs mRNA and eliminating the inhibitory effect of IL-1β on USSs mRNA expression. ASP could increase the content of GAG in cartilage of OA rats and alleviate synovitis.⁵⁰ The loss of PGs is one of the characteristics of OA, which results in tissue destruction and cell loss, and finally leads to the loss of joint function. However, ASP might facilitate the expression of aggrecan and GTs genes, and thus promote PGs synthesis in chondrocytes.⁶⁹

Diabetes

Prediabetes is an extremely dangerous condition for developing diabetes, which is determined by blood glucose variables that are higher than normal, but below the diabetes threshold.⁷⁴

Related research showed that after intragastric administration of ASP, the level of fasting blood glucose was decreased and the abnormal level of fasting serum insulin was improved in streptozotocin (STZ)-induced diabetic and prediabetic mice. Further research found that the homeostasis model evaluation-insulin resistance (HOMA-IR) index of prediabetic mice was decreased significantly and the concentration of serum TC or triglyceride in prediabetic mice or STZ-induced diabetic mice was increased after ASP treatment. At the same time, the concentrations of liver glycogen and muscle glycogen in STZ-induced diabetic mice were increased, but IR-related inflammatory factors IL-6 and TNF-α were decreased. After ASP treatment, the damaged pancreas, liver or adipose tissue of STZ-induced diabetic mice or prediabetic mice were visibly recovered.⁹

Wang et al. found that ASP could observably repair the glucose-producing ability of mice fed with a high-fat diet. The mechanism might be related to the increase of glucokinase expression and the decrease of pyruvate kinase activity. Furthermore, ASP could dramatically increase the activity of hexokinase (HK) in mice fed with a high-fat diet, suggesting that the recovery of HK may also be involved in the process. In addition, ASP notably attenuated IR induced by hyperlipidemia, suggesting that the hypoglycemic ability of ASP was connected with the elimination of IR. It can also alleviate IR via regulating IR/Insulin Receptor Substrate (IRS)/PI3K/Akt/glucose transporter /GSK-3β signal protein and inhibiting the expression of p-JNK in mice fed with a high-fat diet.^40,67

HOMA-β is one of the indicators of promoting insulin secretion, which is often regarded as an evaluation criterion to assess β-cell capacity. Islet β-cells are gradually considered to be the leading part of hypoglycemia by producing and secreting insulin, while ASP might improve islets and resist diabetes through inhibiting β-cell apoptosis. ASP could increase the ratio of Bcl-2/Bax to block the cascade of caspase 9-caspase 3 in islet β-cells. At the same time, inhibition of the exogenous apoptosis pathway driven by caspase-8 further suppresses the activation of subsequent substrate proteins, such as poly [ADP-ribose] polymerase (PARP).²²

Ischemia Reperfusion Injury

Ischemia myocardial reperfusion leads to irreversible tissue damage and cell necrosis, resulting in decreased cardiac function, while cardiotrophin-1 (CT-1) is a cytokine associated with hypertension, myocardial infarction, and other heart diseases. ASP administration could dramatically decrease the myocardial infarction area, increase the activities of CT-1 and antioxidant enzymes, and down-regulate the expression of caspase-12mRNA to alleviate myocardial ischemia-reperfusion injury in rats.⁵⁷

Myocardial ischemia leads to grievous ER stress, such as increased expression of pro-apoptotic C/EBP homologous protein and caspase-12 proteins. ASP could activate the ATF6 arm of UPR and alleviate the harmful ER stress in OGD-induced H9c2 cells and ischemic cardiomyocytes in vivo, as well as remarkably improve the survival molecules of the ER stress response system, including GRP78, GRP94, and PDIA6. Furthermore, it also could decrease pro-apoptotic factors. Accordingly, ASP can attenuate myocardial ischemic injury by restoring ER function, and target UPR ATF6 arm through the AMPK- PGC1α signal.⁵⁶

CIR usually leads to oxidative damage of brain tissue and neurons damage. However, ASP could remarkably increase the activity of antioxidant enzymes, and thus might attenuate the oxidative damage to the brain tissue of CIR animals. In addition, ASP also observably increased the activities of Ach, Na⁺, K⁺-ATP, Ca²⁺, and Mg²⁺-ATP in the brain tissue of CIR animals, and suppressed the activity of acetylcholinesterase, so as to regulate glycogen metabolism and to increase the level of ACh.^25,60,75

Tumor

Neuroblastoma is an extracranial solid malignant tumor, the most prevalent tumor in children and infants, and accounts for about 15% of all childhood cancer deaths. Recent findings suggested that ASP has anti-tumor activity against neuroblastoma SH-SY5Y cells, and its mechanism was related to the suppression of cell proliferation, migration and invasion, as well as the induction of apoptosis. ASP might inhibit neoplasia of SH-SY5Y cells via miR-205 and miR-675-mediated inactivation of PI3K/Akt, ERK1/2, and JAK/STAT pathways. In the meanwhile, KIF1B isoform β (KIF1Bβ) has been shown to be a target for miR-675, while KIF1Bβ is considered an inhibitor of neuroblastoma.^44,45

Leukemia is a heterogeneous neoplastic leukocytic disease, which has negative effects on blood, bone marrow, and the lymphatic system. There are 4 primary types of leukemia, acute lymphoblastic leukemia, AML, chronic lymphocytic leukemia, and myeloid leukemia. ASP could significantly suppress the proliferation of human AML CD34⁺CD38^-cells cultured in vitro. In addition, ASP had an obvious cytotoxic effect on AML K562 cells, especially CD34⁺CD38^-cells enriched by LSC. It was further shown that ASP could exert a significant inhibitory effect on the colony formation of AML CD34 + CD38 cells.⁶³ Furthermore, another study indicated that ASP was capable of inhibiting the proliferation of chronic myeloid leukemia K562 cells, and the mechanism was related to the induction of erythroid differentiation.^16,64

Nanoparticles

Researchers have chemically modified ASP with branched low molecular weight polyethylenimine (PEI) to obtain cationized ASP (cASP) (the reaction process is shown in Figure 6(A)), which was used as a gene vector to transfer the plasmid DNA encoding TGF-β1 into mesenchymal stem cells. cASP is combined with TGF-β1 plasmid to form cASP-pTGF-β1 nanoparticles. Subsequently, rat bone marrow mesenchymal stem cells and human umbilical cord mesenchymal stem cells were used to test the transfection activity of nanoparticles. The results showed that compared with the classical transfection agent liposome 2000, cASP-pTGF-β1 nanoparticles could deliver exogenous genes into cells faster and more effectively with less toxicity.⁷⁶

Figure 6

Chemical modification process.

Poly (lactic-co-glycolicacid) (PLGA) is a prevalently used synthetic biodegradable polymer, which is frequently applied to drug delivery systems because of its remarkable biocompatibility, biodegradability, and controllability of encapsulated drug release, so as to obtain better bioavailability and drug targeting. Gu et al. encapsulated ASP into PLGA to form ASP-PLGA nanoparticles, and then found that ASP-PLGA could significantly promote the proliferation of T and B cells compared with either ASP or PLGA alone.⁷⁷ Subsequently, Gu et al. embedded ASP and model protein antigen ovalbumin (OVA) in PLGA to constitute ASP-PLGA/OVA, and then injected it subcutaneously into mice. The results showed that ASP-PLGA/OVA could stimulate strong and persistent antibody response and induce cellular immune response.⁷⁸ Then, the author embedded ASP-PLGA into PEI to obtain ASP-PLGA-PEI nanoparticles, and proved that the antigen nanoparticles adsorbed by ASP-PLGA-PEI could be effectively internalized by macrophages, resulting in high concentrations of antigens and ASP in macrophages, so that antigens and ASP were transmitted to antigen presenting cells together.⁷⁹

Zhang et al. modified ASP with deoxycholic acid to obtain amphiphilic coupling compound ASP-DOCA, and then embedded doxorubicin (DOX) into ASP-DOCA to obtain DOX/ASP-DOCA nanoparticles. DOX/ASP-DOCA releases DOX in a continuous and pH-dependent manner, and it actively targets HepG2 tumors through the asialoglycoprotein receptor (ASGPR). In an animal model, DOX/ASP-DOCA passively accumulates into tumors through the enhanced permeability and retention effect, which significantly inhibits tumor growth and reduces the side effects of free DOX.⁸⁰ Wang et al. directly linked cholesteryl hemisuccinate (CHEMS) to ASP by esterification to obtain ASP-CHEMS nanoparticles (ACNPs); the reaction process is shown in Figure 6(B). Cur, as a model drug to protect the liver, was then encapsulated into ACNPs to constitute Cur/ACNPs. Through ASGPR-mediated endocytosis, ASP-derived ACNPs have high liver targeting, which could enhance the accumulation of Cur in the liver. Moreover, once Cur is encapsulated into ACNPs, then it has high drug load and good stability, and Cur can be continuously released from Cur/ACNPs, which improves the bioavailability of Cur.⁷

Discussion and Research Prospect

It is known that polysaccharides are one of the most important bioactive constituents in ASR, and there are many extraction methods. In general, the ultrasonic-assisted method may be more efficient for extracting polysaccharides in comparison with the traditional hot water extraction. In order to improve the extraction efficiency of polysaccharides, it is essential that some extraction conditions still need further optimization, such as ultrasonic power, ultrasonic time, and liquid-solid ratio. As the main bioactive components of ASR for tonifying blood, the hematopoietic effect of ASP has attracted much attention. Many studies have proved that ASP could promote the secretion of EPO, increase red blood cell count and hemoglobin content and regulate the release of hepcidin. These effects are associated with hematopoietic factors such as GM-CSF and IL-3, as well as protein pathways including PI3K-Akt, JAK-STAT, and BMP-SMAD. In addition, ASP also could enhance antioxidant enzymes, inhibit tumor cell proliferation, immunostimulation, and protect cardiomyocytes and hepatocytes. In the meantime, the application of ASP nanoparticles in drug delivery has been reported and demonstrated good liver targeting, which provides potential research topics for the interested scholars.

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the National Natural Science Foundation of China (81773882, 81974522) and Key Research and Development Program of Shaanxi Province (2019ZDLSF04-05). This research was also financially supported by Subject Innovation Team of Shaanxi University of Chinese Medicine (2019-YL10) and The Youth Innovation Team of Shaanxi Universities (2020).

ORCID iD

Yu-Ping Tang

References

Zhuang

N-W.

Gao

G-M

et al. Polysaccharide from Angelica sinensis protects chondrocytes from H2O_2-induced apoptosis through its antioxidant effects in vitro. Int J Biol Macromol. 2016;87:322-328.doi:10.1016/j.ijbiomac.2016.02.031

26893055

Lee

J-G.

Hsieh

W-T.

Chen

S-U.

Chiang

B-H

. Hematopoietic and myeloprotective activities of an acidic Angelica sinensis polysaccharide on human CD34⁺ stem cells. J Ethnopharmacol. 2012;139(3):739-745.doi:10.1016/j.jep.2011.11.049

22155392

Cao

X-Q.

Wang

et al. Characterizations and anti-tumor activities of three acidic polysaccharides from Angelica sinensis (Oliv.) Diels. Int J Biol Macromol. 2010;46(1):115-122.doi:10.1016/j.ijbiomac.2009.11.005

19941888

Cao

Sun

Sullivan

et al. Angelica sinensis polysaccharide protects against acetaminophen-induced acute liver injury and cell death by suppressing oxidative stress and hepatic apoptosis in vivo and in vitro. Int J Biol Macromol. 2018;111(Suppl. 1):1133-1139.doi:10.1016/j.ijbiomac.2018.01.139

Wei

Sun

et al. Metabolomics research on the hepatoprotective effect of Angelica sinensis polysaccharides through gas chromatography-mass spectrometry. J Chromatogr B. 2014;973C:45-54.doi:10.1016/j.jchromb.2014.10.009

25464094

Zhang

Zhou

Wang

Cui

Cheng

Wang

K-P

. Structural characterization and in vitro antitumor activity of an acidic polysaccharide from Angelica sinensis (Oliv.) Diels. Carbohydr Polym. 2016;147:401-408.doi:10.1016/j.carbpol.2016.04.002

27178946

Wang

Liu

et al. Self-assembled Angelica sinensis polysaccharide nanoparticles with an instinctive liver-targeting ability as a drug carrier for acute alcoholic liver damage protection. Int J Pharm. 2020;577:118996. doi:10.1016/j.ijpharm.2019.118996

31904402

Jin

Zhao

Huang

Shang

. Isolation, structure and bioactivities of the polysaccharides from Angelica sinensis (Oliv.) Diels: a review. Carbohydr Polym. 2012;89(3):713-722.doi:10.1016/j.carbpol.2012.04.049

24750855

Wang

Cao

Shui

Yang

Tang

Zhang

. Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors. Food Funct. 2015;6(3):902-909.doi:10.1039/C4FO00859F

25630053

10.

Lai

Liu

. Angelica sinensis polysaccharides inhibit endothelial progenitor cell senescence through the reduction of oxidative stress and activation of the Akt/hTERT pathway. Pharm Biol. 2015;53(12):1842-1849.doi:10.3109/13880209.2015.1027779

25845638

11.

Zhuang

Wang

Zhang

. Oxidative stress in osteoarthritis and antioxidant effect of polysaccharide from Angelica sinensis . Int J Biol Macromol. 2018;115:281-286.doi:10.1016/j.ijbiomac.2018.04.083

29673954

12.

Zhou

W-J.

Wang

Zhou

Z-Y.

Song

C-J

. Angelica sinensis polysaccharides promotes apoptosis in human breast cancer cells via CREB-regulated caspase-3 activation. Biochem Biophys Res Commun. 2015;467(3):562-569.doi:10.1016/j.bbrc.2015.09.145

26431878

13.

Liu

J-Y.

Zhang

You

R-X.

Zeng

Guo

Wang

K-P

. Polysaccharide isolated from Angelica sinensis inhibits hepcidin expression in rats with iron deficiency anemia. J Med Food. 2012;15(10):923-929.doi:10.1089/jmf.2012.2231

22985399

14.

Zhao

Wang

Shen

H-L

et al. Structural characterization and radioprotection of bone marrow hematopoiesis of two novel polysaccharides from the root of Angelica sinensis (Oliv.) Diels. Fitoterapia. 2012;83(8):1712-1720.doi:10.1016/j.fitote.2012.09.029

23063893

15.

Cheng

Zhou

Liu

Wang

Zhang

. The effects of polysaccharides from the root of Angelica sinensis on tumor growth and iron metabolism in H22-bearing mice. Food Funct. 2016;7(2):1033-1039.doi:10.1039/C5FO00855G

26757699

16.

Liu

Sui

et al. Structure characterization and anti-leukemia activity of a novel polysaccharide from Angelica sinensis (Oliv.) Diels. Int J Biol Macromol. 2019;121:161-172.doi:10.1016/j.ijbiomac.2018.09.213

30290264

17.

Wei

Xue

et al. Characterization and antioxidative activities of polysaccharide in Chinese Angelica and its processed products. Int J Biol Macromol. 2014;67:195-200.doi:10.1016/j.ijbiomac.2014.03.025

18.

Wang

Guan

. Structural analysis and immunoregulation activity comparison of five polysaccharides from Angelica sinensis . Carbohyd Polym. 2016;140:6-12.doi:10.1016/j.carbpol.2015.12.050

26876821

19.

Liu

Xiao

Ren

et al. Leukemia cells apoptosis by a newly discovered heterogeneous polysaccharide from Angelica sinensis (Oliv). Diels. Carbohyd Polym. 2020;241:116279. doi:10.1016/j.carbpol.2020.116279

32507223

20.

Sun

Tang

. Water-soluble polysaccharides from Angelica sinensis (Oliv.) Diels: Preparation, characterization and bioactivity. Int J Biol Macromol. 2005;36(5):283-289.doi:10.1016/j.ijbiomac.2005.07.005

16129482

21.

Pan

Jiang

. Stimulating effects of polysaccharide from Angelica sinensis on the nonspecific immunity of white shrimps (Litopenaeus vannamei). Fish Shellfish Immunol. 2018;74:170-174.doi:10.1016/j.fsi.2017.12.067

22.

Zhang

Liu

et al. Oral administration of Angelica sinensis polysaccharide protects against pancreatic islets failure in type 2 diabetic mice: Pancreatic β-cell apoptosis inhibition. J Funct Foods. 2019;54(1):361-370.doi:10.1016/j.jff.2019.01.037

23.

Tian

Hao

Yang

Sun

. Optimization conditions for extracting polysaccharide from Angelica sinensis and its antioxidant activities. J Food Drug Anal. 2017;25(4):766-775.doi:10.1016/j.jfda.2016.08.012

28987352

24.

Meng

Yang

. Extraction optimization of Angelica sinensis polysaccharides and its antioxidant activity in vivo . Carbohydr Polym. 2013;94(1):114-119.doi:10.1016/j.carbpol.2013.01.050

23544518

25.

Fan

et al. Extraction and chemical characterization of Angelica sinensis polysaccharides and its antioxidant activity. Carbohydr Polym. 2013;94(2):731-736.doi:10.1016/j.carbpol.2013.02.007

23544627

26.

Zhao

Shi

Yang

Mao

. Extraction of Angelica sinensis polysaccharides using ultrasound-assisted way and its bioactivity. Int J Biol Macromol. 2016;88:44-50.doi:10.1016/j.ijbiomac.2016.01.113

26845475

27.

Zhang

Cheng

Wang

Zhang

Wang

. The action of JAK, SMAD and ERK signal pathways on hepcidin suppression by polysaccharides from Angelica sinensis in rats with iron deficiency anemia. Food Funct. 2014;5(7):1381-1388.doi:10.1039/c4fo00006d

24752529

28.

Liu

P-J.

Hsieh

W-T.

Huang

S-H.

Liao

H-F.

Chiang

B-H

. Hematopoietic effect of water-soluble polysaccharides from Angelica sinensis on mice with acute blood loss. Exp Hematol. 2010;38(6):437-445.doi:10.1016/j.exphem.2010.03.012

20347925

29.

Wang

K-P.

Zeng

Liu

J-Y.

Guo

Zhang

. Inhibitory effect of polysaccharides isolated from Angelica sinensis on hepcidin expression. J Ethnopharmacol. 2011;134(3):944-948.doi:10.1016/j.jep.2011.02.015

21333724

30.

Zhang

M-M.

Zeng

Yao

Wang

K-P

. Study to establish the role of JAK2 and SMAD1/5/8 pathways in the inhibition of hepcidin by polysaccharides from Angelica sinensis . J Ethnopharmacol. 2012;144(2):433-440.doi:10.1016/j.jep.2012.09.040

23036813

31.

Wang

Cheng

Huang

Zeng

Zhang

. Acidic polysaccharide from Angelica sinensis reverses anemia of chronic disease involving the suppression of inflammatory hepcidin and NF-κB activation. Oxid Med Cell Longev. 2017;2017:7601592-13.doi:10.1155/2017/7601592

29147463

32.

Ren

Wang

et al. The effects of Angelica sinensis polysaccharide on tumor growth and iron metabolism by regulating hepcidin in tumor-bearing mice. Cell Physiol Biochem. 2018;47(3):1084-1094.doi:10.1159/000490185

29843136

33.

Wang

et al. Correction of anemia in chronic kidney disease with Angelica sinensis polysaccharide via restoring EPO production and improving iron availability. Front Pharmacol. 2018;9:803. doi:10.3389/fphar.2018.00803

30108502

34.

Liu

Meng

et al. Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathway. BMC Complement Altern Med. 2010;10(1):79-79.doi:10.1186/1472-6882-10-79

21176128

35.

Younas

Aslam

Muhammad

et al. Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats. Pharm Biol. 2017;55(1):108-113.doi:10.1080/13880209.2016.1230635

27925507

36.

Zahra

SK.

Aslam

Javed

et al. Hematopoietic potential of polysaccharides isolated from Angelica sinensis against ACE inhibitor induced anemia in albino rats. Pak Vet J. 2016;36(1):11-15.

37.

965947 Hou

Bao

Shi

. Preparation of blood-deficient model and research of Angelica polysaccharide on enriching blood in chickens. Evid Based Complement Alternat Med. 2012;2012-5.doi:10.1155/2012/965947

22675393

38.

Zhao

T-Y.

Liu

Z-Q.

Yang

et al. Recovery of chemotherapy-induced anemia by Angelica polysaccharides in C57BL/6N mice and elucidation of underlying mechanism. Pak J Zool. 2019;51(5)doi:10.17582/journal.pjz/2019.51.5.1927.1935

39.

Cui

et al. Angelica sinensis polysaccharide maintains the function of hematopoietic stem cells by regulating the TREG/TH17 ratio and thereby induces anti-mitochondrial apoptosis in aplastic anemia. HemaSphere. 2019;3:S1.

40.

Wang

Cao

Wang

et al. Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. Sci Rep. 2016;6:26229. doi:10.1038/srep26229

27189109

41.

Niu

Zhang

Ling

et al. Polysaccharide from Angelica sinensis protects H9c2 cells against oxidative injury and endoplasmic reticulum stress by activating the ATF6 pathway. J Int Med Res. 2018;46(5):1717-1733.doi:10.1177/0300060518758863

29517941

42.

Gao

Zhang

Tian

et al. The antioxidative and hepatoprotective effects comparison of Chinese Angelicaangelica polysaccharide(CAP)and selenizing CAP (sCAP) in CCl₄ induced hepatic injury mice. Int J Biol Macromol. 2017;97:46-54.doi:10.1016/j.ijbiomac.2017.01.013

28064055

43.

Zhang

Xue

Zhou

et al. Angelica polysaccharide alleviates oxidative response damage in HaCaT cells through up-regulation of miR-126. Exp Mol Pathol. 2019;110:104281. doi:10.1016/j.yexmp.2019.104281

31288012

44.

Yang

Shao

Jiang

Sun

Wang

Sun

. Angelica sinensis polysaccharide inhibits proliferation, migration, and invasion by downregulating microRNA-675 in human neuroblastoma cell line SH-SY5Y. Cell Biol Int. 2018;42(7):867-876.doi:10.1002/cbin.10954

29465760

45.

Yang

Shao

Wang

et al. Angelica polysaccharide exhibits antitumor effect in neuroblastoma cell line SH-SY5Y by up-regulation of miR-205. Biofactors. 2019 doi:10.1002/biof.1586 23 Nov 2019.31758846

46.

Zhang

W-F.

Yang

et al. Angelica polysaccharides inhibit the growth and promote the apoptosis of U251 glioma cells in vitro and in vivo. Phytomedicine. 2017;33:21-27.doi:10.1016/j.phymed.2017.06.007

28887916

47.

Wang

Song

Wang

Cui

Zhang

. Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice. Int Immunopharmacol. 2016;31:140-148.doi:10.1016/j.intimp.2015.12.021

26741264

48.

Zhang

et al. Angelica sinensis polysaccharide prevents hematopoietic stem cells senescence in D-galactose-induced aging mouse model. Stem Cells Int. 2017;2017:3508907-12.doi:10.1155/2017/3508907

28491095

49.

Cheng

Yao

Xiang

et al. Effect of Angelica polysaccharide on brain senescence of Nestin-GFP mice induced by D-galactose. Neurochem Int. 2019;122(2):149-156.doi:10.1016/j.neuint.2018.09.003

50.

Wen

Tan

et al. Angelica sinensis polysaccharides stimulated UDP-sugar synthase genes through promoting gene expression of IGF-1 and IGF1R in chondrocytes: promoting anti-osteoarthritic activity. PLoS One. 2014;9(9):e107024 doi:10.1371/journal.pone.0107024

25202993

51.

Mao

W-A.

Sun

Y-Y.

Mao

J-Y

et al. Inhibitory effects of Angelica polysaccharide on activation of mast cells. Evid Based Complement Alternat Med. 2016;2016:1-10.doi:10.1155/2016/6063475

27200102

52.

Xie

Zhang

Wang

Duan

Wang

. Chinese Angelica polysaccharide (CAP) alleviates LPS-induced inflammation and apoptosis by down-regulating COX-1 in PC12 cells. Cell Physiol Biochem. 2018;49(4):1380-1388.doi:10.1159/000493415

30205404

53.

Yin

Guo

Ruan

Zhu

. Angelica polysaccharide protects PC-12 cells from lipopolysaccharide-induced injury via down-regulating microRNA-223. Biomed Pharmacother. 2018;108:1320-1327.doi:10.1016/j.biopha.2018.09.147

30372834

54.

Zhou

Guo

Chen

Liu

. Angelica polysaccharide mitigates lipopolysaccharide-evoked inflammatory injury by regulating microRNA-10a in neuronal cell line HT22. Artif Cells Nanomed Biotechnol. 2019;47(1):3194-3201.doi:10.1080/21691401.2019.1614595

31353963

55.

Wang

Chen

Shi

Wang

Guan

. Possible treatment for cutaneous lichen planus: An in vitro anti-inflammatory role of Angelica polysaccharide in human keratinocytes HaCaT. Int J Immunopath Ph. 2019;33:2058738418821837.

56.

Niu

Zhang

et al. Network pharmacology-based identification of major component of Angelica sinensis and its action mechanism for the treatment of acute myocardial infarction. Biosci Rep. 2018;38(6)

57.

Zhang

et al. Extraction, chemical analysis of Angelica sinensis polysaccharides and antioxidant activity of the polysaccharides in ischemia-reperfusion rats. Int J Biol Macromol. 2010;47(4):546-550.doi:10.1016/j.ijbiomac.2010.07.012

20691723

58.

Fan

et al. Polysaccharides from Angelica and Astragalus exert hepatoprotective effects against carbon-tetrachloride-induced intoxication in mice. Can J Physiol Pharmacol. 2015;93(1):39-43.doi:10.1139/cjpp-2014-0331

25415237

59.

Liu

. Effects of polysaccharide from Angelica sinensis on some related indexes of free radical and energy metabolism after strenuous exercise in rats. Earth Environ Sci. 2019;218:012147.doi:10.1088/1755-1315/218/1/012147

60.

Lei

Fang

et al. Polysaccharides from Angelica sinensis alleviate neuronal cell injury caused by oxidative stress. Neural Regen Res. 2014;9(3):260-267.doi:10.4103/1673-5374.128218

25206810

61.

Zhang

. Free radical scavenging properties and anti-fatigue activities of Angelica sinensis polysaccharides. Adv Mat Res. 2015;1092-1093:1538-1542.doi:10.4028/www.scientific.net/AMR.1092-1093.1538

62.

Zaimy

MA.

Saffarzadeh

Mohammadi

et al. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017;24(6):233-243.doi:10.1038/cgt.2017.16

28574057

63.

Liu

C-Y.

Cai

S-Z

et al. Senescence effects of Angelica sinensis polysaccharides on human acute myelogenous leukemia stem and progenitor cells. Asian Pac J Cancer Prev. 2014;14(11):6549-6556.doi:10.7314/APJCP.2013.14.11.6549

24377566

64.

Wang

Jiang

Song

S-D.

Hua

Z-S.

Wang

J-W.

Wang

Y-P

. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells. Asian Pac J Cancer Prev. 2015;16(9):3715-3721.doi:10.7314/APJCP.2015.16.9.3715

25987027

65.

Wang

F-S.

Fan

J-G.

Zhang

Gao

Wang

H-Y

. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099-2108.doi:10.1002/hep.27406

25164003

66.

Hua

Xue

Zhang

Wei

. Metabonomics study on the hepatoprotective effect of polysaccharides from different preparations of Angelica sinensis . J Ethnopharmacol. 2014;151(3):1090-1099.doi:10.1016/j.jep.2013.12.011

24378353

67.

Wang

Tang

Zheng

et al. Protective effects of Angelica sinensis polysaccharide against hyperglycemia and liver injury in multiple low-dose streptozotocin-induced type 2 diabetic BALB/c mice. Food Funct. 2016;7(12):4889-4897.doi:10.1039/C6FO01196A

27813540

68.

de Magalhaes

JP.

Passos

. Stress, cell senescence and organismal ageing. Mech Ageing Dev. 2018;170:2-9.doi:10.1016/j.mad.2017.07.001

28688962

69.

Qin

Liu

Y-S.

Liu

et al. Effect of Angelica sinensis polysaccharides on osteoarthritis in vivo and in vitro: A possible mechanism to promote proteoglycans synthesis. Evid Based Complement Alternat Med. 2013;2013:794761-15.doi:10.1155/2013/794761

23861713

70.

Pan

Zhu

. Angelica sinensis polysaccharide protects rat cardiomyocytes H9c2 from hypoxia-induced injury by down-regulation of microRNA-22. Biomed Pharmacother. 2018;106:225-231.doi:10.1016/j.biopha.2018.06.120

29960169

71.

Liu

. Anti-fatigue effects of polysaccharide from Angelica sinensis . Mater Sci Eng. 2018;392:052011.doi:10.1088/1757-899X/392/5/052011

72.

Xiao

Xiong

Song

et al. Angelica sinensis polysaccharides ameliorate stress-induced premature senescence of hematopoietic cell via protecting bone marrow stromal cells from oxidative injuries caused by 5-fluorouracil. Int J Mol Sci. 2017;18(11):2265 doi:10.3390/ijms18112265

29143796

73.

Wang

Bao

Chen

. Protective potential of Angelica sinensis polysaccharide extract against ethylene glycol-induced calcium oxalate urolithiasis. Ren Fail. 2018;40(1):618-627.doi:10.1080/0886022X.2018.1496935

30396308

74.

Tabák

AG.

Herder

Rathmann

Brunner

EJ.

Kivimäki

. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-2290.doi:10.1016/S0140-6736(12)60283-9

22683128

75.

Zhu

. Angelica polysaccharide ameliorates memory impairment in Alzheimer’s disease rat through activating BDNF/TrkB/CREB pathway. Exp Biol Med. 2020;245(1):1-10.doi:10.1177/1535370219894558

76.

Deng

Cao

et al. Angelica sinensis polysaccharide nanoparticles as novel non-viral carriers for gene delivery to mesenchymal stem cells. Nanomedicine. 2013;9(8):1181-1191.doi:10.1016/j.nano.2013.05.008

23727125

77.

Zhou

et al. Optimization of Angelica sinensis polysaccharide-loaded poly (lactic-co-glycolicacid) nanoparticles by RSM and its immunological activity in vitro. Int J Biol Macromol. 2018;107(Pt A):222-229.doi:10.1016/j.ijbiomac.2017.08.176

28867235

78.

Liu

Sun

et al. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses. Int J Pharm. 2019;554:72-80.doi:10.1016/j.ijpharm.2018.11.008

30399435

79.

Wusiman

Wang

et al. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses. Carbohydr Polym. 2019;223:115128. doi:10.1016/j.carbpol.2019.115128

31427012

80.

Zhang

Cui

Mei

et al. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer. Carbohydr Polym. 2019;219:143-154.doi:10.1016/j.carbpol.2019.04.041

31151511

The Bioactivities and Potential Clinical Values of Angelica Sinensis Polysaccharides

Abstract

Keywords

Search Strategy

Chemical Composition and Characterization

Extraction Methods and Optimization

Biological Activities

Hematopoietic Activity

Antioxidant Activity

Antitumor Activity

Hepatoprotective Activity

Anti-aging Activity

Anti-inflammatory Activity

Myocardial Protective Activity

Anti-fatigue Activity

Other Activity

Potential Clinical Applications

Anemia

Osteoarthritis

Diabetes

Ischemia Reperfusion Injury

Tumor

Nanoparticles

Discussion and Research Prospect

Footnotes

Declaration of Conflicting Interests

Funding

ORCID iD

References